Cargando…
SAT062 Inhibition Of GIPR Expression Enhances Sulfonylurea-induced Insulin Secretion, And It Was Associated With Changes In ATP Contents
Disclosure: H. Kim: None. J. Lim: None. H. Jung: None. Introduction: Sulfonylurea (SU) might be indispensable for a subset of patients with type 2 diabetes. In our previous study, we collected some patients who were extremely sensitive to SU for optimal glycemic control, then drew several candidate...
Autores principales: | Ah Kim, Hyun, Yoon Lim, Ji, Seung Jung, Hye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553516/ http://dx.doi.org/10.1210/jendso/bvad114.929 |
Ejemplares similares
-
SAT156 Two Cases Of Hypoglycemia From Inhalation Of Heroin Adulterated With A Sulfonylurea
por: Kim, Keun Young, et al.
Publicado: (2023) -
SAT-169 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Glucose- and Sulfonylurea-Induced Insulin Secretion in Rats
por: Sturchler, Emmanuel, et al.
Publicado: (2019) -
SAT-LB110 Sulfonylurea-Induced Hypoglycemia: To Use Octreotide or Not
por: Romeu, Jose, et al.
Publicado: (2020) -
SAT061 Deficiency Of ENaC Excites Pancreatic β Cells To Promote Insulin Secretion
por: Que, Yanting, et al.
Publicado: (2023) -
LBODP062 SGLT2 Inhibition Ameliorates Cognitive And Physical Impairment In Patients With HFpEF And Diabetes
por: Mone, Pasquale, et al.
Publicado: (2022)